News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Betterauds Celebrates 3000 Blog Posts with a Milestone Achievement in Entertainment and Inspirational Blogging

Rev Up Marketers

Betterauds.com is a forefront voice in the industry of entertainment and inspirational content. In the latest development, the company has proudly announced a momentous achievement: the publication of its 3000th blog post. Since its inception in 2019, this esteemed platform has become a cornerstone for compelling storytelling, offering readers an inside look into the lives of Celebrities, Musicians, Authors, Entrepreneurs, and other influential figures across the globe. This significant milestone underscores Betterauds.com's dedication to delivering a rich tapestry of content that resonates with diverse audiences. From in-depth profiles of notable personalities to exclusive interviews, the blog has cemented its reputation as a go-to source for captivating and inspiring content. With more than 1000 exclusive interviews, Betterauds.com has provided its audience with unparalleled insights into the personal and professional journeys of people who have made a substantial impact in their fields. Swati Sukhija Khattar, Co-Founder of Betterauds.com, expressed her excitement about the achievement, stating, "Our 3000th blog post is not just a testament to the tireless efforts of our team but also a celebration of the unwavering support from our readers. We are delighted to continue our mission of informing and inspiring our global audience with content that truly resonates." The blog's unique approach shines through in its focus on uplifting stories from individuals of varied backgrounds, including disabled persons, abuse survivors, U.S. veterans, and emerging entrepreneurs. By highlighting these narratives, Betterauds.com has established itself as a beacon of motivation and resilience, showcasing the human spirit in its most powerful form. In addition to its inspirational content, Betterauds.com offers a rich array of features for pop culture enthusiasts. Its extensive collection of articles on Celebrities, including detailed biographies and career highlights, allows fans to connect more deeply with their favorite stars. This personal touch adds a unique dimension to the blog's celebrity coverage, enhancing the reader's engagement with the content. Among its many achievements, Betterauds.com proudly boasts over 1000 interviews, reflecting its commitment to presenting diverse perspectives and valuable insights from around the world. These interviews not only highlight personal success stories but also offer a platform for voices that may otherwise remain unheard. The impact and quality of Betterauds.com's content have been recognized by major news outlets, further affirming the blog's influence in the entertainment and inspirational spheres. As it celebrates this landmark achievement, Betterauds.com remains committed to its mission of producing high-quality, engaging, and informative content. About the Company - Betterauds.com Founded in 2019, Betterauds.com is a premier entertainment blog dedicated to sharing the stories of Celebrities, Musicians, Authors, Entrepreneurs, YouTubers, and more. The blog focuses on illuminating the successes and inspirational journeys of individuals, making it a leading source for engaging and motivational content. Potential clients can visit the Betterauds.com for the latest updates and to explore the wealth of stories that Betterauds.com has to offer. Contact Details Betterauds Rajiv Khattar editor@betterauds.com Company Website https://betterauds.com/

August 14, 2024 11:29 AM Eastern Daylight Time

Image
Article thumbnail News Release

Notable Live Announces Partnership with NFL and Tennessee Titans Great, Chris “CJ2K” Johnson

Notable Live

Notable Live, a digital platform that facilitates exceptional fan experiences is today announcing that former NFL and Tennessee Titans running back Chris “CJ2K” Johnson has joined its team as a brand ambassador focused on athlete relations and outreach. Johnson joins the Notable Live team to introduce athletes to the platform and encourage current and former athletes to extend the fan experience beyond the playing field through in-person and virtual events, e-commerce offerings, and curated fan experiences. “Over the past year I’ve developed a meaningful relationship with the Notable Live team to connect with my fans, build a community, and help my legacy live on by sharing items from my playing days with my fans,” said Johnson. “I look forward to growing my relationship with Notable Live and sharing with some of my former teammates and colleagues the unique opportunity the platform provides.” “This is an exciting day for Notable Live. From day one, Chris utilized the Notable Live platform to create unique activation opportunities for his fans and quickly became an asset to our company,” said Mike Antonucci, co-founder and CEO of Notable Live. “We are thrilled to expand our relationship with Chris as a former player and now power user of the platform,” said Antonucci. “We look forward to what we can accomplish together and remain focused on bringing new and unique opportunities to the Notable Live community.” Fans can browse and bid on current inventory from Johnson and other NFL legends in the Notable Live on eBay Store ( https://www.ebay.com/str/notablelive ). About Notable Live Notable Live was co-founded in 2018 by fan Mike Antonucci and NFL Hall of Fame player Emmitt Smith to create a unique platform providing fans with unparalleled access to their favorite notables via virtual interactive events, in-person experiences, and curated e-commerce offerings. Notable Live has a mobile app available on the App Store and Google Play that puts fans “in the room” with their favorite notables for memorable virtual experiences. Connect with Notable Live at www.notable.live or on Instagram, Facebook or Twitter. Contact Details Notable Live Shannon Gross +1 318-537-2967 shannon.gross@notable.live Company Website https://www.notable.live/

August 14, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

AmeriLife Names Michael Tobitsch Executive Vice President and Head of Corporate Development

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions, announced today that Michael Tobitsch has been named Executive Vice President and Head of Corporate Development. Reporting to AmeriLife’s Chairman and Chief Executive Officer, Scott R. Perry, Tobitsch will lead the company’s corporate development efforts to source and execute acquisition opportunities, assess their strategic fit, and work closely with AmeriLife’s affiliates and partners to support the company’s growth objectives. In addition, Tobitsch will oversee innovations to the company’s affiliate onboarding processes and ensure the cultural and technical integrations for new partners is efficient and seamless. "For the last seven years, AmeriLife’s Chief Financial Officer Jim Quinn has served as an incredible steward of our corporate development efforts, overseeing a level of growth unsurpassed in AmeriLife’s 50-plus year history,” said Perry. “As our business becomes more complex and Jim’s remit continues to grow, we’re thrilled to welcome Michael and have a leader fully dedicated to AmeriLife’s expansive M&A activities. His experience and innovative approach to partnership development will undoubtedly propel our strategic initiatives forward, enhancing our ability to expand our distribution opportunities and help AmeriLife realize its growth ambitions.” “After 15 terrific years at Marsh McLennan, it’s a privilege to join Scott and the high-performing AmeriLife team to help continue their impressive growth journey,” added Tobitsch. “AmeriLife operates from a position of strength, and I look forward to helping deliver best-in-class products, solutions, and capabilities through a high-impact, programmatic acquisition agenda.” Tobitsch joins AmeriLife from global professional services company Marsh McLennan in New York. As Managing Director of the firm’s Strategy & Corporate Development group, he managed a high-performing team of investment professionals who together deployed more than $1 billion of capital annually into global acquisitions across the insurance and investment management industries. Tobitsch began his career in investment banking with Wells Fargo Securities. Tobitsch received his B.S. from Boston University’s Questrom School of Business. An avid traveler and New York Mets fan, Tobitsch resides in Connecticut with his wife and two young daughters. ### About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as an industry leader in developing, marketing and distributing life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a national distribution network of over 300,000 agents and financial professionals and more than 120 marketing organizations and insurance agencies. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado media@amerilife.com Partnership Inquiries Patrick Nichols corporatedevelopment@amerilife.com Company Website https://amerilife.com/

August 13, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Safety Shot, Inc. (NASDAQ: SHOT): Upside Confirmed by Scientific Research

CGR-SHOT

As the wellness industry evolves, there is increasing interest in products that address specific consumer needs beyond traditional health solutions. One area with limited innovation has been managing the effects of alcohol consumption. Safety Shot, Inc. (Nasdaq: SHOT) is making strides in this space with its flagship drink. Safety Shot is a patented beverage designed to lower blood alcohol content (BAC) by accelerating alcohol metabolism. It also aims to enhance clarity, energy, and mood. Backed by recent scientific research and expanding its distribution network, Safety Shot is positioning itself as a key tool for responsible alcohol consumption. Scientific Backing of Safety Shot The foundation of Safety Shot’s market proposition is its scientific validation, supported by significant results from a clinical trial conducted by the Center for Applied Health Sciences (CAHS) and announced on August 12, 2024. This double-blind, randomized, placebo-controlled study demonstrated the product's effectiveness in reducing BAC. Participants aged 24 to 46, with varying body weights, showed a dramatic reduction in BAC, with some experiencing rates that dropped 30%–50% faster than the placebo group. Key findings included consistent reductions in both breath and blood alcohol content, enhanced energy levels, and improved concentration. Participants also reported less head discomfort and fatigue, further substantiating the product's claims. Chief Operations Officer and co-inventor David Sandler highlighted, “These results are revolutionizing the wellness space as we continue to pioneer the world’s most innovative functional beverages.” Dr. Tim Ziegenfuss, CEO of CAHS, echoed this sentiment: “These results are highly encouraging, showcasing Safety Shot’s potential as a beneficial supplement for individuals consuming alcohol.” Expansion Through Partnerships Safety Shot, Inc. has pursued expansion through strategic partnerships, significantly enhancing its market reach. In early June, the company announced their partnership with Mr. Checkout, a national network of independent distributors and grocery distributors. This collaboration aims to introduce Safety Shot to over 200,000 independent retail locations across the U.S., leveraging Mr. Checkout’s expertise in launching and scaling innovative products. Chief Revenue Officer Josh Wagner expressed optimism about the partnership: “This is a significant step forward in exploring new verticals of accessibility for our revolutionary product. We are confident that with Mr. Checkout’s support, we will be able to expand Safety Shot’s presence into diversified retailers to meet our customers where they prefer to shop.” Expanding in New York and New Jersey Furthering its expansion efforts, Safety Shot partnered with Prime CSB, a boutique broker with a strong presence in New York and New Jersey, to enhance its footprint in these key markets. Prime CSB’s personalized distribution approach is expected to help Safety Shot gain a solid foothold in these regions, particularly as demand surges during the peak summer season. Pharmacy Integration with Capital Drugs Safety Shot’s distribution efforts extend into the pharmacy sector through a deal with Capital Drugs, placing its product in 300 pharmacies nationwide. This partnership aligns Safety Shot with its wellness mission, allowing it to reach a like-minded consumer base that frequents pharmacies for health and wellness products. Northeast Presence via Atlantic Beverage Distributors To further bolster its market presence in the Northeast, Safety Shot partnered with Atlantic Beverage Distributors, a key player in Massachusetts and Rhode Island’s beverage markets. This collaboration is expected to significantly enhance Safety Shot’s presence in the region, thanks to Atlantic Beverage Distributors’ deep understanding of the market and extensive distribution network. Wagner noted, “Their expertise in the beverage and spirits industry and dedication to working with specialty products align perfectly with where we want to take Safety Shot as we continue to grow and expand.” Nationwide Reach with KeHE Distributors The company’s nationwide expansion strategy received a significant boost through a partnership with KeHE Distributors, a leading distributor of natural and organic products in North America. This alliance is expected to bring Safety Shot to thousands of new retail locations across the country, capitalizing on KeHE’s vast distribution network. Conclusion With robust scientific evidence and a series of strategic partnerships, Safety Shot, Inc. is poised to become a leader in the wellness and dietary supplement industries. As it continues to disrupt the market and redefine responsible alcohol consumption, investors may want to be closely watching its progress. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

August 13, 2024 06:00 AM Eastern Daylight Time

Article thumbnail News Release

AAMS/ADM e Regolamentazione del Gioco in Italia

AM Europe

Il gioco d'azzardo in Italia è un tema complesso e soggetto a una normativa rigorosa. In questo contesto, i cosiddetti "casino non AAMS" rappresentano un argomento di crescente interesse. Ma cosa sono esattamente e quali sono le implicazioni legali? Cosa sono i Casino Non AAMS? AAMS è l'acronimo di Amministrazione Autonoma dei Monopoli di Stato, l'ente governativo italiano preposto alla regolamentazione del gioco d'azzardo. I NewsDirect casino non AAMS sono, quindi, piattaforme di gioco online che operano senza la licenza rilasciata dall'AAMS. La Regolamentazione del Gioco in Italia Il panorama del gioco d'azzardo in Italia è caratterizzato da una regolamentazione severa, volta a proteggere i giocatori e contrastare il gioco illegale. L'AAMS svolge un ruolo fondamentale nel rilasciare le licenze e nel monitorare l'attività dei concessionari. Le principali caratteristiche della normativa italiana sono: Licenza obbligatoria: Ogni operatore di gioco d'azzardo deve ottenere una licenza dall'AAMS per poter operare legalmente in Italia. Tutela dei giocatori: La legge italiana prevede misure di protezione dei giocatori, come i limiti di deposito e i sistemi di autoesclusione. Lotta al gioco illegale: L'AAMS e le autorità competenti sono impegnate nella lotta contro il gioco illegale e i siti non autorizzati. I Rischi dei Casino Non AAMS Giocare su piattaforme non autorizzate comporta diversi rischi: Mancanza di garanzie: I giocatori non hanno alcuna garanzia sulla sicurezza dei loro dati personali e finanziari. Gioco illegale: Utilizzare piattaforme non autorizzate è illegale e può comportare sanzioni. Mancanza di tutela: In caso di dispute o problemi, i giocatori non hanno alcuna tutela legale. Conclusione La scelta di giocare su un casino online deve essere fatta con consapevolezza. Optare per piattaforme autorizzate dall'AAMS è fondamentale per garantire sicurezza, trasparenza e tutela dei propri diritti. Ricordiamo sempre che il gioco d'azzardo deve essere considerato un divertimento e non una fonte di reddito. È importante sottolineare che questo articolo ha carattere informativo e non costituisce consulenza legale. Per maggiori informazioni: Sito ufficiale dell'AAMS: [ adm.gov.it ] Nota bene: La normativa italiana sul gioco d'azzardo è soggetta a modifiche. Per informazioni aggiornate, consultare sempre le fonti ufficiali. Vuoi saperne di più su un argomento specifico legato al gioco d'azzardo in Italia? Contact Details Vladimiro Lorenzo +49 2735 7227 Vladimiro.l@clo.com

August 12, 2024 11:30 PM Eastern Daylight Time

Image
Article thumbnail News Release

K3 Holdings and Alpine LA Properties Congratulate Team USA for Winning Paris Olympics Medal Count

K3 Holdings

K3 Holdings, a privately held real estate investment firm with extensive holdings throughout the United States and Alpine LA Properties, a leasing company providing newly remodeled apartments at affordable rates in Los Angeles, congratulated Team USA for their outstanding performance in the Paris Olympics. Following more than two weeks of competition and lifetimes of preparation, athletes representing the United States won 126 medals (40 gold) leading all other countries at the conclusion of the games in Paris. "Congratulations to Team USA for showcasing the true spirit of excellence and determination, bringing home the most medals and making us all proud,” stated Michael Kadisha, a Principal of K3 Holdings. "Winning the most medals is a triumph of skill and perseverance, and more so, a testament to the unity and resilience that define the American spirit. Dedication, hard work, and a never-give-up attitude leads to greatness, and we are all inspired by the performance of our athletes in Paris.” "In sports, as in life, the way we handle victory says as much about us as the victory itself. Gratitude and humility elevate every achievement. Winning with grace and losing with dignity are the hallmarks of true champions,” Michael Kadisha continued. “The K3 Holdings and Alpine teams were impressed at how Team USA proved themselves to be real winners by celebrating their victories while honoring their opponents with respect and gratitude.” The Olympics serve as a unique platform where nations from every corner of the globe come together in a spirit of friendly competition. Beyond the medals and records, the Olympics foster an environment where cultural exchange and mutual understanding thrive. In a world often divided by differences, the Olympics create a space where adversaries can engage in dialogue, learn from one another, and find common ground through shared values of sportsmanship and respect. "The Olympics is a powerful testament to how people from diverse cultures and backgrounds can come together to achieve greatness," stated Nathan Kadisha, a K3 Principal. "The actions of Olympic athletes in Paris show us that dedication, perseverance, and mutual respect transcend borders and ideologies. These are the values that can truly unite us and drive real change beyond the games." “We are excited that Los Angeles will be hosting the Olympics four years from now,” Michael Kadisha said. “By watching athletes from rival nations compete with honor and integrity, in our own community, we will once again be reminded that even in competition, there is room for cooperation, empathy, and the possibility of resolving conflicts peacefully.” ### For more information or to schedule an interview with a K3 spokesperson, please contact Dan Rene at 202-329-8357 or dan@danrene.com Contact Details K3 Holdings/Alpine LA Properties Dan Rene +1 202-329-8357 dan@danrene.com Company Website https://k3holdings.com/

August 12, 2024 11:30 AM Eastern Daylight Time

Article thumbnail News Release

Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of Next-Generation Treatment for Major Depressive Disorder

MarketJar

Major Depressive Disorder (MDD) was the third leading cause of global disease burden in 2008, according to the World Health Organization, with projections that it could become the leading cause by 2030. MDD is a severe mental health condition marked by persistent sadness, loss of interest in activities, and difficulties in daily functioning. 1 Lithium, a well-known mood stabilizer, has been used off-label for MDD, but its application is limited by safety concerns due to its narrow therapeutic window. In response to this unmet need, Alzamend Neuro, Inc. (NASDAQ:ALZN), a clinical-stage biopharmaceutical company, is dedicated to developing innovative treatments for neurological and psychiatric disorders, including MDD. The company's latest effort involves a promising partnership with Massachusetts General Hospital (MGH) to conduct a Phase II clinical trial of AL001, a next-generation lithium-based therapeutic candidate aimed at improving the safety and effectiveness of lithium treatment for MDD. Dr. Ovidiu Andronesi, an Associate Professor of Radiology at Harvard University, will lead the study. This trial aims to compare AL001's effectiveness and safety against a marketed lithium carbonate product by examining lithium levels in the brain and its structures. Alzamend Neuro, Inc. (NASDAQ:ALZN) previously completed a Phase IIA trial that identified a maximum tolerated dose (MTD) for AL001. This dose is designed to provide lithium at a safe and effective level without the need for frequent monitoring, unlike current lithium treatments that are limited by chronic toxicity and poor physicochemical properties. The primary goal of this study is to determine the ideal dose of AL001 that can achieve similar or better effectiveness and safety compared to existing lithium salts. Alzamend is optimistic that the study will meet regulatory safety standards through the FDA's Section 505(b)(2) pathway, which allows for new formulations of approved drugs. Stephan Jackman, Chief Executive Officer of Alzamend Neuro, Inc. (NASDAQ:ALZN), expressed enthusiasm about the partnership with Massachusetts General Hospital and Dr. Andronesi for the pivotal study of AL001. He highlighted the potential of AL001 to be a next-generation lithium product with an improved safety profile and enhanced brain biodistribution, which could eliminate the need for routine therapeutic drug monitoring (TDM). Jackman emphasized that developing such a product would represent a significant advancement over existing lithium-based treatments and could have a positive impact on the over 21 million Americans affected by Major Depressive Disorder (MDD). Alzamend plans to share more details about the study’s timeline and market opportunities in the near future. Alzamend Neuro and Massachusetts General Hospital Launch Phase II Trials of AL001 for Bipolar Disorder and Alzheimer’s Alzamend Neuro, Inc. (NASDAQ:ALZN) is also partnering with MGH to conduct Phase II clinical trials of AL001 for patients with bipolar disorder (BD) and Alzheimer’s disease. These trials are also led by Dr. Ovidiu Andronesi, an Associate Professor of Radiology at Harvard University. Lithium, the first mood stabilizer approved by the U.S. Food and Drug Administration (FDA), remains the gold standard for treating bipolar disorder (BD). With over 35 years of use, its safety profile is well established, which may reduce regulatory hurdles. This trial aims to compare the increase in brain lithium levels between AL001 and a commonly marketed lithium salt in BD patients, seeking to optimize dosing for enhanced effectiveness and safety. As for the Alzheimer’s trial, a cohort of healthy subjects will be studied to compare their plasma and brain pharmacokinetics with those of Alzheimer's patients. This trial aims to evaluate the increase in brain lithium levels and its distribution between AL001 and a commonly marketed lithium salt in both Alzheimer's patients and healthy subjects. Alzamend Neuro Secures $25 Million Funding to Advance Clinical Trials Alzamend Neuro, Inc. (NASDAQ:ALZN) recently secured the initial two tranches under a $25 million purchase agreement. This investment will drive the progress of Alzamend 's clinical trials and the development of next-generation treatments for Alzheimer’s, bipolar disorder, MDD, and PTSD. CEO Stephan Jackman highlighted the company’s commitment to achieving clinical milestones and transforming lithium-based therapies for millions of people affected by these conditions. Click here for more information about Alzamend Neuro, Inc. (NASDAQ:ALZN). [1] https://www.ncbi.nlm.nih.gov/books/NBK559078/ Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Alzamend Neuro, Inc. Market Jar Media Inc. was paid $1,500 for the production and publishing of this article by Alzamend Neuro, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.’s engagement by Alzamend Neuro, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-alzn. 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on pressreach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on pressreach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management’s expectations regarding Alzamend Neuro, Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Alzamend Neuro, Inc.’s industry; (b) market opportunity; (c) Alzamend Neuro, Inc.’s business plans and strategies; (d) services that Alzamend Neuro, Inc. intends to offer; (e) Alzamend Neuro, Inc.’s milestone projections and targets; (f) Alzamend Neuro, Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Alzamend Neuro, Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Alzamend Neuro, Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Alzamend Neuro, Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Alzamend Neuro, Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Alzamend Neuro, Inc.’s ability to enter into contractual arrangements with additional parties; (e) the accuracy of budgeted costs and expenditures; (f) Alzamend Neuro, Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Alzamend Neuro, Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Alzamend Neuro, Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Alzamend Neuro, Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Alzamend Neuro, Inc.’s business operations (e) Alzamend Neuro, Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, Alzamend Neuro, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Alzamend Neuro, Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Alzamend Neuro, Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Alzamend Neuro, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Alzamend Neuro, Inc. or such entities and are not necessarily indicative of future performance of Alzamend Neuro, Inc. or such entities. 8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on pressreach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

August 12, 2024 09:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

Revenue Management Solutions Named “Best Use of Research and Surveys” In PR Daily’s 2024 Social Media, Digital & Content Marketing Awards

Revenue Management Solutions

Revenue Management Solutions (RMS), a global leader in data-driven analytics and tech-enabled solutions for the restaurant industry, proudly announces its win at the 2024 Social Media, Digital & Content Marketing Awards, presented by PR Daily. For its impactful Restaurant Trend Reports, RMS took home the award in the "Use of Research/Surveys" category. The awards ceremony, held on August 1 at the prestigious Yale Club in New York City, celebrated the hidden stars and talents behind impressive social and content marketing campaigns. Attendees gathered to honor professionals across various categories, from Best Social Media Campaign to Digital Community Engagement. "Winning this award is a testament to our team's dedication and expertise in delivering insightful content that drives restaurant industry success," said Jana Zschieschang, RMS Chief Brand Officer. “Thousands of restaurant industry influencers access our Quick-Service Trend Report every month to gain clear and concise insights to navigate the ever-changing landscape of the restaurant business." RMS launched its QSR Trend Reports during the pandemic, a time of rapid change for the restaurant industry. What began as a tool to condense and simplify fast-food trends has evolved into a respected source for restaurant pricing, sales and traffic referenced by clients and leading news outlets, including Reuters, The Wall Street Journal, Bloomberg and trusted restaurant trade publications. PR Daily's Content Marketing Awards spotlight the most impactful and innovative work in the field. Brendan Gannon, Senior Marketing Manager for the Ragan/PR Daily Awards programs, praised RMS for their creative approach, noting “The winners set a new standard in content creation with exceptional storytelling and strategic insights. Their work exemplifies the power of data-driven content in capturing audience attention and driving meaningful results." As RMS celebrates this significant achievement, it continues to lead the industry in data-driven tech solutions that empower restaurant brands to confidently navigate challenges such as inflation and labor costs. For 30 years, Revenue Management Solutions has partnered with restaurant brands to deliver actionable insights and data-driven recommendations that boost sales, streamline costs, and maximize profitability. Their AI-powered solutions support over 100,000 locations worldwide, enabling brands to unlock the power of their data and thrive in a competitive market. About Revenue Management Solutions Revenue Management Solutions (RMS) partners with restaurant brands to provide data-driven solutions that drive sales, streamline costs, and enhance profitability. With AI-powered analytics, RMS supports over 100,000 locations globally, empowering brands to navigate industry challenges confidently. For more information, visit www.revenuemanage.com. About Ragan Communications and PR Daily Ragan Communications has been a trusted source of news, training, and intelligence for more than 50 years, serving internal and external communicators and business executives. PRDaily.com and Ragan.com are read by over 600,000 communicators monthly, providing insights and resources across various communication fields. Contact Details Tracy Henderson +1 720-989-3530 tracy@centerreachcommunication.com Company Website https://www.revenuemanage.com

August 12, 2024 08:33 AM Eastern Daylight Time

Article thumbnail News Release

Canada’s Gift Baskets Unveils New Line of Corporate Gift Baskets

Rev Up Marketers

Canada’s Gift Baskets is excited to announce the launch of its new line of corporate gift baskets, designed to enhance business relationships and recognize employee achievements. The new collection, available now, features a variety of high-quality, customizable gift baskets suitable for any corporate occasion. The corporate gift baskets from Canada’s Gift Baskets offer a sophisticated selection of gourmet treats, luxury items, and customizable options to cater to the unique needs of businesses. These baskets are perfect for client appreciation, employee recognition, corporate events, and holiday gifts. "We understand the importance of making a lasting impression in the business world," said Paul Dolabjian, CEO of Canada’s Gift Baskets. "Our new corporate gift baskets are curated with premium products and are customizable to reflect the values and branding of any company." Key features of the new corporate gift basket line include: Premium Quality Customization Options Variety of Choices Nationwide Delivery Canada’s Gift Baskets is committed to providing exceptional service and high-quality products. The launch of the new corporate gift baskets line underscores the company’s dedication to helping businesses build and maintain strong professional relationships. For more information about the new corporate gift baskets, visit Canada’s Gift Baskets. About Canada’s Gift Baskets Canada's Gift Baskets is a leading provider of premium gift baskets and hampers, renowned for its dedication to quality, creativity, and customer satisfaction. Based in Toronto, ON, Canada, the company has been serving customers across the nation for over a decade, offering a diverse range of beautifully curated gift baskets for every occasion, from personal celebrations to corporate events. Canada’s Gift Baskets has earned a reputation for its exceptional service, from the meticulous creation of each gift basket to the reliable and timely delivery. Whether it’s for a holiday, a milestone celebration, or to strengthen business relationships, Canada’s Gift Baskets offers the perfect solution for all gifting needs. With the launch of its new corporate gift basket line, Canada’s Gift Baskets continues to demonstrate its leadership in the industry, offering businesses across Canada a sophisticated and customizable way to show appreciation and recognize achievements. Contact Details Canada Gift Baskets Paul Dolabjian contact@canadasgiftbaskets.ca Company Website https://canadasgiftbaskets.ca/

August 09, 2024 06:33 AM Eastern Daylight Time

Image
1 ... 56789 ... 397